Switching to antipsychotic monotherapy and quality of life: A randomized controlled trial

Mushde Shakir, Peter N. van Harten, Adriaan W. Hoogendoorn, Anne E. Willems, Diederik E. Tenback

Open source

DOI
10.1016/j.schres.2026.07.030
Published
2026-11
Container
Schizophrenia Research
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.schres.2026.07.030,
  title = {Switching to antipsychotic monotherapy and quality of life: A randomized controlled trial},
  author = {Mushde Shakir and Peter N. van Harten and Adriaan W. Hoogendoorn and Anne E. Willems and Diederik E. Tenback},
  year = {2026},
  journal = {Schizophrenia Research},
  doi = {10.1016/j.schres.2026.07.030},
  url = {https://doi.org/10.1016/j.schres.2026.07.030}
}

RIS

TY  - JOUR
TI  - Switching to antipsychotic monotherapy and quality of life: A randomized controlled trial
AU  - Mushde Shakir
AU  - Peter N. van Harten
AU  - Adriaan W. Hoogendoorn
AU  - Anne E. Willems
AU  - Diederik E. Tenback
PY  - 2026
JO  - Schizophrenia Research
DO  - 10.1016/j.schres.2026.07.030
UR  - https://doi.org/10.1016/j.schres.2026.07.030
ER  - 

APA

Shakir, M., Harten, P. N. V., Hoogendoorn, A. W., Willems, A. E., & Tenback, D. E. (2026). Switching to antipsychotic monotherapy and quality of life: A randomized controlled trial. Schizophrenia Research. https://doi.org/10.1016/j.schres.2026.07.030

Source records